tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

WINT Stock Latest News

Windtree Therapeutics announces presentation highlighting istaroxime
The FlyWindtree Therapeutics announces presentation highlighting istaroxime
6d ago
WINT
Windtree Therapeutics announces new istaroxime patent filing
PremiumThe Fly
Windtree Therapeutics announces new istaroxime patent filing
13d ago
WINT
Windtree Therapeutics announces partnership with New Growth Advisors
PremiumThe Fly
Windtree Therapeutics announces partnership with New Growth Advisors
18d ago
WINT
Windtree Therapeutics Reports Q3 2024 Financial Results
PremiumCompany Announcements
Windtree Therapeutics Reports Q3 2024 Financial Results
25d ago
WINT
Windtree Therapeutics reports Q3 EPS ($4.23) vs. ($15.47) last year
PremiumThe Fly
Windtree Therapeutics reports Q3 EPS ($4.23) vs. ($15.47) last year
25d ago
WINT
Windtree Therapeutics Appoints Jed Latkin as New CEO
PremiumCompany AnnouncementsWindtree Therapeutics Appoints Jed Latkin as New CEO
1M ago
8K
WINT
Windtree Therapeutics announces CEO Fraser to retire, Latkin to succeed
Premium
The Fly
Windtree Therapeutics announces CEO Fraser to retire, Latkin to succeed
1M ago
WINT
Windtree Therapeutics Inc (WINT) Q3 Earnings Cheat Sheet
Premium
Pre-Earnings
Windtree Therapeutics Inc (WINT) Q3 Earnings Cheat Sheet
2M ago
WINT
Windtree Therapeutics issued Hong Kong patent for istaroxime
PremiumThe Fly
Windtree Therapeutics issued Hong Kong patent for istaroxime
2M ago
WINT
Windtree Therapeutics initiates SEISMiC C study of istaroxime
PremiumThe Fly
Windtree Therapeutics initiates SEISMiC C study of istaroxime
2M ago
WINT
Windtree Therapeutics completes national phase filings for istaroxime
PremiumThe Fly
Windtree Therapeutics completes national phase filings for istaroxime
2M ago
WINT
Windtree Therapeutics announces issuance of istaroxime patent for Japan
PremiumThe Fly
Windtree Therapeutics announces issuance of istaroxime patent for Japan
2M ago
WINT
Windtree announces trial design of Phase 2b study of Istaroxime published
PremiumThe FlyWindtree announces trial design of Phase 2b study of Istaroxime published
2M ago
WINT
Windtree Therapeutics Appoints New Senior VP and CFO
Premium
Company Announcements
Windtree Therapeutics Appoints New Senior VP and CFO
3M ago
8K
WINT
Windtree Therapeutics to hold a virtual investor day
Premium
The Fly
Windtree Therapeutics to hold a virtual investor day
3M ago
WINT
Windtree Therapeutics Updates Investor Presentation Materials
PremiumCompany Announcements
Windtree Therapeutics Updates Investor Presentation Materials
3M ago
8K
WINT
Windtree Therapeutics announces Phase 2b topline results of istaroxime
PremiumThe Fly
Windtree Therapeutics announces Phase 2b topline results of istaroxime
3M ago
WINT
Windtree Therapeutics announces topline results from 2b SEISMiC Extension Study
PremiumThe Fly
Windtree Therapeutics announces topline results from 2b SEISMiC Extension Study
3M ago
WINT
Windtree Therapeutics Expands Stock and Restructures Finances
PremiumCompany Announcements
Windtree Therapeutics Expands Stock and Restructures Finances
3M ago
8K
WINT
Windtree Therapeutics completes enrollment of Phase 2b study of istaroxime
PremiumThe FlyWindtree Therapeutics completes enrollment of Phase 2b study of istaroxime
4M ago
WINT
Windtree Therapeutics files to sell 26.67M shares of common stock for holders
Premium
The Fly
Windtree Therapeutics files to sell 26.67M shares of common stock for holders
4M ago
WINT
Windtree Therapeutics reports Q2 EPS ($20.91) vs. ($29.47) last year
Premium
The Fly
Windtree Therapeutics reports Q2 EPS ($20.91) vs. ($29.47) last year
4M ago
WINT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >